World's leading pharma services company rated highest in overall
satisfaction
RESEARCH TRIANGLE PARK, N.C., April 10 /PRNewswire/ -- Quintiles Transnational Corp. today announced that an independently conducted study of clinical investigator sites across Europe placed Quintiles first in overall satisfaction. Quintiles also rated first in several other indicators of a clinical investigator's commitment to work with the world's leading pharmaceutical services provider.
Eighty-four percent of sites indicated that they were satisfied or extremely satisfied with their relationship with Quintiles.
The study, blinded and conducted by a third party, asked more than 300 European clinical investigators in 18 countries to rate their relationships and experience with Clinical Research Organizations (CROs). Investigators recruit patients and collect data for CROs and their pharmaceutical and biotechnology sponsors in studies that test drugs for safety and efficacy. Quintiles and eight other CROs were rated on 15 attributes by the investigator sites, including overall satisfaction, relationship building and allocation of resources for projects, including staff time.
"It is especially pleasing to see these results from all of our efforts to build strong relationships with investigators," said Lindy Jones, Vice President, Clinical Operations, Western Europe and Africa. "Because of our hard work, it is clear the sites are willing to devote more of their resources to projects they conduct with Quintiles than other CROs."
Clinical sites were asked to assign a percentage of resources -- such
as time spent on patient recruitment -- that they had used on clinical
studies with each CRO. Quintiles was allocated 38% of resources by the
sites, with the nearest competitor being assigned only 13%, according to
the survey. As for expected allocation of resources in the future, sites
plan to continue giving additional
'/>"/>
| SOURCE Quintiles Transnational Corp. Copyright©2008 PR Newswire. All rights reserved |